Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction
25 May 2019 (00:00 - 00:00)
Organised by:
About the speaker
Cleveland Clinic Hospital, Cleveland (United States of America)
7 More presentations in this session
Doctor M. Kolomiiets (Kharkiv, UA)
Associate Professor M. Simoes (Ribeirao Preto, BR)
Miss R. Woolley (Groningen, NL)
Miss A. Di Bona (Padova, IT)
Access the full session
The Event
Heart Failure 2019
25 May - 28 May 2019
